Poland· PL-100405314
Nivalin
A anticholinesterases product containing galantamini hydrobromidum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Galantamini hydrobromidum is registered in 2 of 19 countries.
Countries holding a registration under ATC N07AA (anticholinesterases), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Galantamini hydrobromidum · ATC N07AA
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Galantamini hydrobromidum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N07AA
- ATC class
- Anticholinesterases
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991371760
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Galantamini hydrobromidum in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAcumor XL 16mg capsulesViatris UK Healthcare Ltd
- FinlandGalafixAlfred E.Tiefenbacher GmbH & Co. KG
- SpainGALANTAMINA AUROBINDO 16 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFGLaboratorios Aurobindo S.L.U.
- United StatesGalantamineUpsher-Smith Laboratories, LLC
- SwedenGalantamin Actavis 16 mg Depotkapsel, hårdActavis Group PTC ehf.
- FranceGALANTAMINE ARROW LAB LP 16 mg, gélule à libération prolongéeARROW GENERIQUES
- BelgiumGalantamin Sandoz 16 mgSandoz
- NetherlandsBergal SR 16 mg harde capsules met verlengde afgifteKrka d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Galantamin Actavis, Galantamin Krka
- Belgium · Reminyl
- Bulgaria · Галантамин Дс, Галсия Sr
- Germany · Galanaxiro, Galantamin 1 A Pharma
- Denmark · Galantamin Krka, Galantamin Stada
- Spain · Galantamina Aurovitas Spain, Galantamina Cinfa
- Finland · Galantamin Krka, Galantamin Orion
- France · Galantamine Lp Arrow Lab, Galantamine Lp Biogaran
- United Kingdom (Northern Ireland) · Consion Xl, Gaalin
- Greece · Aneprosil, Galantamine Pharmathen
- Ireland · Galsya Sr
- Iceland · Galantamin Stada
- Italy · Galnora, Reminyl
- Liechtenstein · Reminyl
- Luxembourg · Reminyl, Reminyl (Emballage De Départ)
- Latvia · Nivalin
- Malta · Galantamine Syri Pharma
- Netherlands · Bergal Sr, Galantamine Hydrobromide Aurobindo
- Norway · Galantamin Krka, Reminyl
- Portugal · Galantamina Azevedos, Galantamina Bluelife
- Romania · Galsya, Reminyl
- Sweden · Galantamin Actavis, Galantamin Krka
- Slovenia · Galabar Sr, Galema Sr
- Slovakia · Galantamin Viatris, Galsya Sr
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f83a86d4-ad86-4b68-acda-bbe05e4a182d GET /v1/drugs/f83a86d4-ad86-4b68-acda-bbe05e4a182d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "2,5 mg/ml",
"packaging": "05909991371760 ¦ Rp ¦ 128049\n10 amp. 1 ml",
"substance": "Galantamini hydrobromidum 2.5 mg/ml",
"common_name": "Galantamini hydrobromidum",
"pl_product_id": "100405314",
"pozwolenie_nr": "132/18",
"auth_procedure": "IR",
"authorisation_validity": "2028-05-08"
}See everything about galantamini hydrobromidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.